CBT
HQL

Central Bank & Trust’s abrdn Life Sciences Investors HQL Stock Holding History

Central Bank & Trust’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-684
Closed -$14K – 313
2014
Q2 		$14K Buy
+684
New +$14.4K 0.01% 235
2014
Q1 		– Sell
-684
Closed -$14K – 310
2013
Q4 		$14K Buy
684
+12
+2% +$233 0.01% 235
2013
Q3 		$13K Buy
672
+13
+2% +$249 0.01% 237
2013
Q2 		$12.3K Buy
+659
New +$11.9K 0.01% 242

Other funds holding HQL

NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Central Bank & Trust's HQL Position: Q3 2014 in Review

Central Bank & Trust sold out of abrdn Life Sciences Investors (HQL) in Q3 2014, closing a stake of 684 shares — an estimated $14K sold.

Central Bank & Trust first reported a position in HQL in Q2 2013 and held it in 4 quarters. The position peaked at $14K in Q2 2014. 49 funds tracked by Wall St. Rank hold HQL as of Q3 2014.

  • Central Bank & Trust reported no remaining abrdn Life Sciences Investors position as of Q3 2014 after selling out during the quarter.
  • Central Bank & Trust sold 684 abrdn Life Sciences Investors shares in Q3 2014, an estimated $14K.
  • Central Bank & Trust first reported a position in abrdn Life Sciences Investors in Q2 2013 and held it in 4 quarters.
  • Central Bank & Trust's abrdn Life Sciences Investors position peaked at $14K in Q2 2014.
  • 49 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q3 2014.

Based on Central Bank & Trust's 13F filing for Q3 2014, filed 16 Oct 2014.